Insulin resistance and the endothelium

The American Journal of Medicine
Willa A HsuehManuel J Quiñones

Abstract

There is increasing evidence of a parallel progression between insulin resistance and endothelial dysfunction, suggesting a close association between insulin action and the endothelium. Numerous studies have demonstrated that endothelial dysfunction occurs early in the insulin-resistant state and is predictive of future cardiovascular events. Similarly, insulin resistance has been associated with the metabolic syndrome, which also increases the risk of adverse cardiovascular outcomes. Approaches that improve endothelial dysfunction, such as treatment with statins, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or peroxisome proliferator-activated receptor gamma ligands, have been shown to prevent both diabetes and cardiovascular disease. This article reviews the relation between endothelial dysfunction and cardiovascular disease, assesses the endothelium in the spectrum of insulin resistance, and examines the effect of the thiazolidinediones on endothelial function.

References

May 1, 1991·The Journal of Clinical Investigation·B TesfamariamR A Cohen
Sep 1, 1997·The Journal of Clinical Investigation·H O SteinbergA D Baron
Sep 3, 1998·The Journal of Biological Chemistry·U Laufs, J K Liao
Oct 16, 1999·Hypertension·M McIntyreA F Dominiczak
Mar 1, 2000·British Journal of Pharmacology·D Bishop-Bailey
Jun 7, 2000·The Journal of Clinical Investigation·A DaughertyL A Cassis
Jun 8, 2000·Annals of the New York Academy of Sciences·A Daugherty, L Cassis
Feb 13, 2001·Annual Review of Medicine·S Mudaliar, R R Henry
Mar 7, 2001·The Journal of Clinical Endocrinology and Metabolism·H E LebovitzUNKNOWN Rosiglitazone Clinical Trials Study Group
May 4, 2001·The American Journal of Cardiology·B Williams
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Aug 2, 2001·Journal of Atherosclerosis and Thrombosis·Y WatanabeH Yamaguchi
Oct 26, 2001·JAMA : the Journal of the American Medical Association·S YusufUNKNOWN HOPE Study Investigators
Nov 6, 2001·The American Journal of Cardiology·J Plutzky
Nov 7, 2001·Coronary Artery Disease·V Schächinger, A M Zeiher
Dec 6, 2001·Diabetes Research and Clinical Practice·H Matsuoka

❮ Previous
Next ❯

Citations

Mar 3, 2006·Current Atherosclerosis Reports·Dat DoRobert Chilton
Jul 22, 2005·Current Diabetes Reports·Manuel J QuiñonesChristopher J Lyon
Aug 10, 2007·Current Diabetes Reports·Yi-Xin Jim Wang
Nov 11, 2008·International Journal of Impotence Research·A AversaG Spera
Jun 5, 2010·Journal of Clinical and Experimental Neuropsychology·H BruehlA Convit
Mar 29, 2008·Metabolic Syndrome and Related Disorders·Craig ChangGloria Lena Vega
Mar 29, 2008·Metabolic Syndrome and Related Disorders·David Siegel, Arthur L M Swislocki
Feb 17, 2010·Metabolic Syndrome and Related Disorders·David Siegel, Arthur L M Swislocki
Jan 13, 2005·Rheumatology·Christopher D BuckleyKarim Raza
Mar 16, 2005·Current Opinion in Lipidology·Mike F Laker
Jul 2, 2005·Current Opinion in Lipidology·Suman Lahirya, Asim K Duttaroy
Jun 10, 2010·PLoS Neglected Tropical Diseases·Maria Aparecida A FigueiredoMaria Glória Teixeira
Feb 8, 2011·PloS One·Caterina MammiDavide Lauro
Jul 18, 2009·Journal of the American Society of Nephrology : JASN·Giovana S Di MarcoMarcus Brand
Dec 27, 2005·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Zoran HajdukovićSlavica Raden
Dec 29, 2011·Frontiers in Bioscience (Scholar Edition)·Meghana PansuriaHong Wang
May 23, 2012·Cardiovascular Journal of Africa·Mashudu MudauHans Strijdom
Dec 17, 2008·Environmental Health Perspectives·Alexandra SchneiderRobert B Devlin
Feb 13, 2015·International Journal of Molecular Sciences·Chung-Yuan ChenShyi-Jang Shin
May 25, 2012·International Journal of Cardiology·Christian CadedduGiuseppe Mercuro
Dec 8, 2009·Journal of Pediatric and Adolescent Gynecology·S M Bhattacharya, M Ghosh
Jan 15, 2008·Free Radical Biology & Medicine·Angelo AvogaroGian Paolo Fadini
Jun 15, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·P LoriaN Carulli
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·André T Guay
Jan 9, 2007·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Wellington de Paula MartinsRosana M Dos Reis
Sep 9, 2006·Endocrinology and Metabolism Clinics of North America·Martin M HartgeThomas Unger
Sep 14, 2012·Experimental Diabetes Research·Ana Paula Villela DantasMaria Helena Catelli de Carvalho
Aug 24, 2005·Journal of Internal Medicine·C VitaleG M C Rosano
Jul 20, 2007·Journal of Clinical Pharmacy and Therapeutics·G LupattelliE Mannarino
Jun 1, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Tevfik DemirAdil Esen
Jan 13, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·S KasayamaM Koga
Dec 8, 2006·Annals of the New York Academy of Sciences·Christos KalofoutisAnastasios Kalofoutis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.